Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Treatment.com International ( (TSE:TRUE) ) has provided an update.
Treatment.com AI Inc. has announced that its subsidiary, Rocket Doctor, has partnered with a California managed care plan to provide healthcare services to approximately 450,000 Medicaid members. This partnership is expected to enhance healthcare access by offering tele-urgent care, specialty services, and primary care through a virtual care platform, reducing unnecessary emergency room visits and wait times, while generating an anticipated additional annual recurring revenue of approximately US$1.2 million.
More about Treatment.com International
YTD Price Performance: 23.64%
Average Trading Volume: 7,739
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.37M
Find detailed analytics on TRUE stock on TipRanks’ Stock Analysis page.
